4d09
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==PDE2a catalytic domain in complex with a brain penetrant inhibitor== | ==PDE2a catalytic domain in complex with a brain penetrant inhibitor== | ||
| - | <StructureSection load='4d09' size='340' side='right' caption='[[4d09]], [[Resolution|resolution]] 2.50Å' scene=''> | + | <StructureSection load='4d09' size='340' side='right'caption='[[4d09]], [[Resolution|resolution]] 2.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4d09]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D09 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D09 FirstGlance]. <br> | <table><tr><td colspan='2'>[[4d09]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D09 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D09 FirstGlance]. <br> | ||
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Phosphodiesterase|Phosphodiesterase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 25: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | [[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Andres, J I]] | [[Category: Andres, J I]] | ||
[[Category: Buijnsters, P]] | [[Category: Buijnsters, P]] | ||
Revision as of 18:16, 14 August 2019
PDE2a catalytic domain in complex with a brain penetrant inhibitor
| |||||||||||
Categories: 3',5'-cyclic-nucleotide phosphodiesterase | Large Structures | Andres, J I | Buijnsters, P | DeAngelis, M | Langlois, X | Rombouts, F | Sanderson, W | Trabanco, A | Tresadern, G | VanHoof, G | VanRoosbroeck, Y | Animal | Cyclic nucleotide phosphodiesterase | Disease model | Drug evaluation | Hydrolase | Phosphodiesterase 2 inhibitor | Phosphodiesterase inhibitor | Preclinical | Protein binding | Structure-activity relationship | Type 2 | Type 4
